JPWO2022014680A1 - - Google Patents
Info
- Publication number
- JPWO2022014680A1 JPWO2022014680A1 JP2022536446A JP2022536446A JPWO2022014680A1 JP WO2022014680 A1 JPWO2022014680 A1 JP WO2022014680A1 JP 2022536446 A JP2022536446 A JP 2022536446A JP 2022536446 A JP2022536446 A JP 2022536446A JP WO2022014680 A1 JPWO2022014680 A1 JP WO2022014680A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020122864 | 2020-07-17 | ||
| JP2020122864 | 2020-07-17 | ||
| PCT/JP2021/026649 WO2022014680A1 (ja) | 2020-07-17 | 2021-07-15 | 置換ピペリジン化合物及びその用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022014680A1 true JPWO2022014680A1 (https=) | 2022-01-20 |
| JP7190612B2 JP7190612B2 (ja) | 2022-12-15 |
| JPWO2022014680A5 JPWO2022014680A5 (https=) | 2022-12-16 |
Family
ID=79291962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022536446A Active JP7190612B2 (ja) | 2020-07-17 | 2021-07-15 | 置換ピペリジン化合物及びその用途 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US11479552B2 (https=) |
| EP (1) | EP4151277B1 (https=) |
| JP (1) | JP7190612B2 (https=) |
| KR (1) | KR20230040953A (https=) |
| CN (3) | CN119235864A (https=) |
| AR (1) | AR122973A1 (https=) |
| AU (1) | AU2021308053A1 (https=) |
| BR (1) | BR112022026161A2 (https=) |
| CA (1) | CA3187835A1 (https=) |
| CL (1) | CL2022003666A1 (https=) |
| CO (1) | CO2022018446A2 (https=) |
| DK (1) | DK4151277T3 (https=) |
| FI (1) | FI4151277T3 (https=) |
| IL (1) | IL299125B2 (https=) |
| JO (1) | JOP20220345A1 (https=) |
| LT (1) | LT4151277T (https=) |
| MX (1) | MX2022016388A (https=) |
| PE (1) | PE20231103A1 (https=) |
| PH (1) | PH12022553488A1 (https=) |
| TW (1) | TWI888599B (https=) |
| UA (1) | UA129636C2 (https=) |
| WO (1) | WO2022014680A1 (https=) |
| ZA (1) | ZA202213562B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4065585B1 (en) | 2019-11-25 | 2025-08-20 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| US12006330B2 (en) | 2020-12-21 | 2024-06-11 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| JP7591592B2 (ja) * | 2022-01-14 | 2024-11-28 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 置換ピペリジン化合物を含有する医薬 |
| JPWO2023136279A1 (https=) * | 2022-01-14 | 2023-07-20 | ||
| WO2024075825A1 (ja) * | 2022-10-07 | 2024-04-11 | キッセイ薬品工業株式会社 | シクロペンタン化合物 |
| EP4611745A1 (en) * | 2022-10-31 | 2025-09-10 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
| WO2024128305A1 (ja) | 2022-12-16 | 2024-06-20 | 第一三共株式会社 | ２－アザビシクロ［３．１．１］ヘプタン化合物 |
| EP4719397A1 (en) | 2023-06-02 | 2026-04-08 | Takeda Pharmaceutical Company Limited | Use of an orexin 2 receptor agonist for improving respiratory function during sleep |
| WO2025124698A1 (en) | 2023-12-12 | 2025-06-19 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
| TW202542165A (zh) | 2023-12-19 | 2025-11-01 | 瑞士商愛杜西亞製藥有限公司 | 大環食慾素激動劑 |
| WO2025137359A1 (en) | 2023-12-20 | 2025-06-26 | Eisai R&D Management Co., Ltd. | Assay methods to identify a disease |
| WO2025229493A1 (en) | 2024-04-29 | 2025-11-06 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005028438A1 (ja) * | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | 新規ピペリジン誘導体 |
| JP2008517032A (ja) * | 2004-10-20 | 2008-05-22 | ノイロサーチ アクティーゼルスカブ | 新規なジアザ二環式アリール誘導体及びその医薬用途 |
| JP2016512536A (ja) * | 2013-03-13 | 2016-04-28 | ヤンセン ファーマシューティカ エヌ．ベー． | 置換した７−アザビシクル及びオレキシン受容体調節因子としてのそれらの使用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG34208A1 (en) | 1995-03-01 | 1996-12-06 | Guy Andrew Vaz | Blast and fragment resistant polyurethane boot sole for safety footwear |
| EP0828751A4 (en) | 1995-05-05 | 1999-01-20 | Human Genome Sciences Inc | HUMAN NEUROPEPTIDE RECEPTOR |
| US6309854B1 (en) | 1996-12-17 | 2001-10-30 | Smithkline Beecham Corporation | Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72 |
| US6159605A (en) | 1997-02-18 | 2000-12-12 | Dainichiseika Color & Chemicals Mfg. Co., Ltd. | Ink-jet recording sheet |
| US5935814A (en) | 1997-04-30 | 1999-08-10 | Smithkline Beecham Corporation | Polynucleotides encoding HFGAN72Y receptor |
| US6020157A (en) | 1997-04-30 | 2000-02-01 | Smithkline Beecham Corporation | Polynucleotides encoding HFGAN72X receptor |
| US6166193A (en) | 1997-07-25 | 2000-12-26 | Board Of Regents, University Of Texas System | Polynucleotides encoding MY1 receptor |
| KR100327888B1 (ko) | 1999-07-14 | 2002-03-09 | 정숭렬 | 도로포장 파손촉진 시험장치의 무선제어 시스템 |
| JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
-
2021
- 2021-07-15 TW TW110126031A patent/TWI888599B/zh active
- 2021-07-15 DK DK21842047.9T patent/DK4151277T3/da active
- 2021-07-15 PE PE2022003006A patent/PE20231103A1/es unknown
- 2021-07-15 PH PH1/2022/553488A patent/PH12022553488A1/en unknown
- 2021-07-15 CN CN202411459551.4A patent/CN119235864A/zh active Pending
- 2021-07-15 AR ARP210101982A patent/AR122973A1/es unknown
- 2021-07-15 UA UAA202204882A patent/UA129636C2/uk unknown
- 2021-07-15 EP EP21842047.9A patent/EP4151277B1/en active Active
- 2021-07-15 WO PCT/JP2021/026649 patent/WO2022014680A1/ja not_active Ceased
- 2021-07-15 IL IL299125A patent/IL299125B2/en unknown
- 2021-07-15 AU AU2021308053A patent/AU2021308053A1/en active Pending
- 2021-07-15 CN CN202180044081.3A patent/CN115884971B/zh active Active
- 2021-07-15 US US17/376,452 patent/US11479552B2/en active Active
- 2021-07-15 CN CN202411462171.6A patent/CN119258067A/zh active Pending
- 2021-07-15 CA CA3187835A patent/CA3187835A1/en active Pending
- 2021-07-15 FI FIEP21842047.9T patent/FI4151277T3/fi active
- 2021-07-15 LT LTEPPCT/JP2021/026649T patent/LT4151277T/lt unknown
- 2021-07-15 KR KR1020227044679A patent/KR20230040953A/ko active Pending
- 2021-07-15 JP JP2022536446A patent/JP7190612B2/ja active Active
- 2021-07-15 BR BR112022026161A patent/BR112022026161A2/pt unknown
- 2021-07-15 MX MX2022016388A patent/MX2022016388A/es unknown
-
2022
- 2022-12-14 ZA ZA2022/13562A patent/ZA202213562B/en unknown
- 2022-12-20 CL CL2022003666A patent/CL2022003666A1/es unknown
- 2022-12-20 CO CONC2022/0018446A patent/CO2022018446A2/es unknown
- 2022-12-21 JO JOJO/P/2022/0345A patent/JOP20220345A1/ar unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005028438A1 (ja) * | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | 新規ピペリジン誘導体 |
| JP2008517032A (ja) * | 2004-10-20 | 2008-05-22 | ノイロサーチ アクティーゼルスカブ | 新規なジアザ二環式アリール誘導体及びその医薬用途 |
| JP2016512536A (ja) * | 2013-03-13 | 2016-04-28 | ヤンセン ファーマシューティカ エヌ．ベー． | 置換した７−アザビシクル及びオレキシン受容体調節因子としてのそれらの使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| IL299125B1 (en) | 2025-11-01 |
| CL2022003666A1 (es) | 2023-05-26 |
| CA3187835A1 (en) | 2022-01-20 |
| CN115884971B (zh) | 2024-11-05 |
| US20220017517A1 (en) | 2022-01-20 |
| DK4151277T3 (da) | 2026-04-13 |
| ZA202213562B (en) | 2023-10-25 |
| AU2021308053A1 (en) | 2023-02-02 |
| IL299125A (en) | 2023-02-01 |
| JOP20220345A1 (ar) | 2022-12-21 |
| TW202542144A (zh) | 2025-11-01 |
| EP4151277A1 (en) | 2023-03-22 |
| TWI888599B (zh) | 2025-07-01 |
| EP4151277B1 (en) | 2026-01-28 |
| MX2022016388A (es) | 2023-01-30 |
| TW202216705A (zh) | 2022-05-01 |
| JP7190612B2 (ja) | 2022-12-15 |
| US11479552B2 (en) | 2022-10-25 |
| IL299125B2 (en) | 2026-03-01 |
| FI4151277T3 (fi) | 2026-03-27 |
| CN119258067A (zh) | 2025-01-07 |
| WO2022014680A1 (ja) | 2022-01-20 |
| CN115884971A (zh) | 2023-03-31 |
| UA129636C2 (uk) | 2025-06-18 |
| PE20231103A1 (es) | 2023-07-19 |
| CN119235864A (zh) | 2025-01-03 |
| AR122973A1 (es) | 2022-10-19 |
| EP4151277A4 (en) | 2024-06-26 |
| BR112022026161A2 (pt) | 2023-01-31 |
| KR20230040953A (ko) | 2023-03-23 |
| CO2022018446A2 (es) | 2023-03-07 |
| LT4151277T (lt) | 2026-04-10 |
| PH12022553488A1 (en) | 2024-04-22 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221026 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221026 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20221026 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221028 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221115 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221205 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7190612 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |